Varaico: Literature-Extracted Genetic Variants

Gene:GLA
Variant:p.W287*
Back to variants list

GLA

NM_000169.3:p.W287*

Associated Papers

Physical Fitness and Physical Function in Patients With Fabry Disease: A Cross-Sectional Multicentre Study.

Vitturi N et al.

Journal of Cachexia, Sarcopenia and Muscle, 2026

Phenotypic Diversity on Cardiac Magnetic Resonance in a Han Family With Fabry Disease.

Li J et al.

Cjc Open, 2025

Increased Soluble Interleukin 6 Receptors in Fabry Disease.

Lenzini L et al.

Journal of Clinical Medicine, 2023

A phase II, multicenter, open-label trial to evaluate the safety and efficacy of ISU303 (Agalsidase beta) in patients with Fabry disease.

Hwang S et al.

Medicine, 2022

Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease.

Kim IY et al.

Kidney Research and Clinical Practice, 2021

The Cardiovascular Phenotype in Fabry Disease: New Findings in the Research Field.

Sorriento D et al.

International Journal of Molecular Sciences, 2021

Assessing Lysosomal Disorders in the NGS Era: Identification of Novel Rare Variants.

Encarnação M et al.

International Journal of Molecular Sciences, 2020

Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation.

Duarte AJ et al.

Stem Cell Research, 2020

Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.

Choi JH et al.

Medicine, 2017

Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy.

Liguori R et al.

Plos One, 2017

Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.

Massaccesi L et al.

Clinical Biochemistry, 2011

The pulvinar sign: frequency and clinical correlations in Fabry disease.

Burlina AP et al.

Journal of Neurology, 2008

Lysosomal leukocyte beta-D-glucuronidase during enzyme replacement therapy in Fabry disease.

Goi G et al.

Biochimica Et Biophysica Acta, 2005

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.

Schäfer E et al.

Human Mutation, 2005

Detection of 8 new mutations in the alpha-galactosidase A gene in Fabry disease.

Davies J et al.

Human Molecular Genetics, 1994

Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.

Eng CM et al.

Human Mutation, 1994

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."